National Guideline Clearinghouse | Human growth hormone (somatropin) for the treatment of growth failure in children.

Guideline Title
Human growth hormone (somatropin) for the treatment of growth failure in children.

Bibliographic Source(s)
National Institute for Health and Clinical Excellence (NICE). Human growth hormone (somatropin) for the treatment of growth failure in children. London (UK): National Institute for Health and Clinical Excellence (NICE); 2010 May. 49 p. (Technology appraisal guidance; no. 188).

Guideline Status
This is the current release of the guideline.


full-text:
National Guideline Clearinghouse | Human growth hormone (somatropin) for the treatment of growth failure in children.